Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel

Oncogene volume 20, pages 7098–7103 (2001)Cite this article

Abstract

Rel/NF-κB transcription factors control a variety of cellular processes, such as cell growth and apoptosis, that are relevant to oncogenesis, and mutations in genes encoding Rel/NF-κB transcription factors have been found in several human lymphoid cell cancers. In this study, we have used a sensitive cell outgrowth assay to demonstrate that wild-type human c-Rel can malignantly transform primary chicken spleen cells, and that transformation by c-Rel is accelerated by co-expression of Bc1-2. Full-length mouse c-Rel can also transform chicken spleen cells. These results are the first demonstration of a lymphoid cell malignant transforming ability for mammalian Rel/NF-κB transcription factors, and implicate c-Rel as a molecular target for cancer therapeutics.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IA, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson Jr J, Lu L, Lewis DB, Tibshirani R, Sherlock G, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Warnke R, Levy R, Wilson W, Grever MR, Byrd JC, Botstein D, Brown PO, Staudt LM . 2000 Nature 403: 503–511

  • Ballard DW, Walker WH, Doerre S, Sista P, Molitor JA, Dixon EP, Peffer NJ, Hannink M, Greene WC . 1990 Cell 63: 803–814

  • Barkett M, Gilmore TD . 1999 Oncogene 18: 6910–6924

  • Barkett M, Dooher JE, Lemonnier L, Simmons L, Scarpati JN, Wang Y, Gilmore TD . 2001 Biochim. Biophys. Acta 1526: 25–36

  • Barth TFE, Bentz M, Leithäuser F, Stilgenbauers, Siebert R, Schlotter M, Schlenk RF, Döhner H, Möller P . 2001 Genes Chromosomes Cancer 31: 316–325

  • Barth TFE, Döhner H, Werner CA, Stilgenbauer S, Schlotter M, Pawlita M, Lichter P, Möller P, Bentz M . 1998 Blood 91: 4321–4330

  • Bohlander SK . 2000 Cytogenet. Cell Genet. 91: 52–56

  • Brownell E, Mittereder N, Rice NR . 1989 Oncogene 4: 935–942

  • Cheng EH, Kirsch DG, Clem RJ, Ravi R, Kastan MB, Bedi A, Ueno K, Hardwick JM . 1997 Science 278: 1966–1968

  • Epinat J-C, Gilmore TD . 1999 Oncogene 18: 6896–6909

  • Gilmore TD . 1999a Oncogene 18: 6842–6844

  • Gilmore TD . 1999b Oncogene 18: 6925–6937

  • Gilmore TD, Temin HM . 1986 Cell 44: 791–800

  • Gilmore TD, Epinat J-C, Barkett M . 2000 Misregulation of a signal transduction pathway: role of Rel/NF-κB complexes in oncogenesis. In: DNA Alterations in Cancer: Genetic and Epigenetic Changes (ed. M Ehrlich) Eaton Publishing, Natick, MA pp. 121–136

  • Gilmore TD, White DW, Sarkar S, Sif S . 1995 Malignant transformation of cells by the v-Rel oncoprotein. In: The DNA Provirus: Howard Temin's Scientific Legacy Cooper GM, Greenberg Temin R and Sugden B (eds) American Society of Microbiology: Washington DC pp. 109–128

  • Grossmann M, O'Reilly LA, Gugasyan R, Strasser A, Adams JM, Gerondakis S . 2000 EMBO J. 19: 6351–6360

  • Henderson E, Miller G, Robinson J, Heston L . 1997 Virology 76: 152–163

  • Heuber AO, Evan GI . 1998 Trends Genet. 14: 364–367

  • Hoelzer JD, Lewis RB, Wasmuth CR, Bose Jr HR . 1980 Virology 100: 462–474

  • Houldsworth J, Mathew S, Rao PH, Dyomina K, Louie DC, Parsa N, Offit K, Chaganti RSK . 1996 Blood 87: 25–29

  • Hrdlicková R, Nehyba J, Humphries EH . 1994 J. Virol. 68: 2371–2382

  • Huang Z . 2000 Oncogene 19: 6627–6631

  • Joos S, Otaño-Joos MI, Ziegler S, Brüderlein S, du Manoir S, Bentz M, Möller P, Lichter P . 1996 Blood 87: 1571–1578

  • Kaye KM, Izumi KM, Li H, Johannsen E, Davidson D, Longnecker R, Kieff E . 1999 J. Virol. 73: 10525–10530

  • Kralova J, Schatzle JD, Bargmann W, Bose Jr HR . 1994 J. Virol. 68: 2073–2083

  • Lu D, Thompson JD, Gorski GK, Rice NR, Mayer MG, Yunis JJ . 1991 Oncogene 6: 1235–1241

  • Mainville CA, Parmar K, Unnikrishnan I, Gong L, Raffel GD, Rosenberg N . 2001 J.Virol. 75: 1816–1823

  • Mosialos G, Hamer P, Capobianco AJ, Laursen R, Gilmore TD . 1991 Mol. Cell. Biol. 11: 5867–5877

  • Pahl H . 1999 Oncogene 18: 6853–6866

  • Rao PH, Houldsworth J, Dyomina K, Parsa NZ, Cigudosa JC, Louie DC, Popplewell L, Offit K, Jhanwar SC, Chaganti RSK . 1998 Blood 92: 234–240

  • Rayet B, Gélinas C . 1999 Oncogene 18: 6938–6947

  • Sif S, Capobianco AJ, Gilmore TD . 1993 Oncogene 8: 2501–2509

  • White DW, Gilmore TD . 1996 Oncogene 13: 891–899

  • White DW, Gilmore TD . 1997 Science 276: 185

  • White DW, Pitoc GA, Gilmore TD . 1996 Mol. Cell. Biol. 16: 1169–1178

Download references

Acknowledgements

We thank N Rice for human c-Rel antiserum, P Schreiber-Schwartz and DJ Waxman for Bc1-2 and Bc1-xL antisera, D Kalaitzidis for creating the JD214BS+ retroviral vector for the expression of human c-rel and for helpful discussions, and G Cooper for comments on the manuscript. This work was supported by NIH grant CA47763 (to TD Gilmore). C Cormier performed research as part of the Honors Research Program in Biochemistry & Molecular Biology, and was supported by funds from the Beckman Foundation and from the Undergraduate Research Opportunities Program of Boston University.

Author information

Authors and Affiliations

  1. Department of Biology, Boston University, 5 Cummington Street, Boston, MA 02215, Massachusetts, USA

    Thomas D Gilmore, Catherine Cormier, Jims Jean-Jacques & Maria-Emily Gapuzan

Authors
  1. Thomas D Gilmore
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Catherine Cormier
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jims Jean-Jacques
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Maria-Emily Gapuzan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas D Gilmore.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gilmore, T., Cormier, C., Jean-Jacques, J. et al. Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel. Oncogene 20, 7098–7103 (2001). https://doi.org/10.1038/sj.onc.1204898

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204898

Keywords

This article is cited by

Search

Advanced search

Quick links